Export 5 results:
[ Author(Desc)] Title Type Year
Filters: Author is Mahalingam, Gokulnath  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Mahalingam G, Periyasami Y, Arjunan P, Subaschandrabose RKumar, Mathivanan TVenthan, Mathew RSusan, Devi KRamya, Premkumar PSamuel, Muliyil J, Srivastava A, Moorthy M, Marepally S.  2022.  Omicron infection increases IgG binding to spike protein of predecessor variants.. J Med Virol. DOI:10.1002/jmv.28419.
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Karuppusamy KV, Periyasami Y, Mohan A, Subramaniyam K, M S, Rajendran V, Moorthy M, Varghese GM, Mohankumar KM, Thangavel S, Srivastava A, Marepally S.  2024.  SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.. Mol Ther. DOI:10.1016/j.ymthe.2024.02.028.
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Periyasami Y, M S, Thangavel S, Mohankumar KM, Moorthy M, Velayudhan SR, Srivastava A, Marepally S.  2022.  Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System.. Front Pharmacol. 13:840727. DOI:10.3389/fphar.2022.840727.
Mahalingam G, Arjunan P, Periyasami Y, Dhyani AKumar, Devaraju N, Rajendiran V, Christopher ACrystal, Kt RDevi, Dhanasingh I, Thangavel S, Murugesan M, Moorthy M, Srivastava A, Marepally S.  2023.  Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor.. Sci Rep. 13(1):8743. DOI:10.1038/s41598-023-35070-2.
Mahalingam G, Marepally S.  2024.  In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome antigenic competition.. Mol Ther. 32(4):873-874. DOI:10.1016/j.ymthe.2024.03.011.